Find a Researcher
Search for Moffitt research faculty by a group or name
Find a Clinical Trial
Search for a clinical trial by disease type or name
Advanced Search
To learn more, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Research
Moffitt Cancer Center is the only NCI-designated Comprehensive Cancer Center based in Florida. With its singular focus on cancer, Moffitt has worked tirelessly in the areas of patient care, research and education since opening in Tampa in 1986. Moffitt’s research focuses on cutting-edge discoveries that can be rapidly translated into improved diagnostic, preventive and therapeutic advances.
Centers & Institutes
Moffitt’s Centers and Institutes promote translation across research and the clinic to address the needs of the catchment area.
Divisions & Departments
Moffitt’s academic structure provides a supportive and collaborative environment for faculty career development in cancer research.
Research Programs
Our five research programs focus on scientific themes, which together provide Moffitt’s multidimensional, strong approach to defeating cancer.
Research Faculty
Moffitt employs over 150 faculty representing a diverse group of scientists and physicians, all dedicated to cancer research.
Research Teams
Investigators are encouraged to form teams around specific topics, no matter how informal, to innovate and take research in new directions.
Community Outreach, Engagement & Equity
Moffitt’s research partnerships reflect a longstanding commitment to working with the community, academia and industry in the fight against cancer.
Education & Training
Moffitt supports training of the next generation of scientists. Opportunities range from high school to graduate students and postdoctoral trainees.
Shared Resources
Shared Resources provide Moffitt investigators access to the latest technologies and highly skilled services to foster productivity.
Innovation
Moffitt discoveries have enhanced our understanding of cancer and led to multiple licensing and collaboration opportunities within the biomedical industry.
LATEST NEWS
- Patients Treated with Immune Checkpoint Inhibitors Have Better Quality of Life, Moffitt Analysis Shows
- Moffitt Researchers Develop Model to Predict Non-Small Cell Lung Cancer Patient Outcomes to Immunotherapy
- Adoptive Cell Therapy Plus Checkpoint Inhibitors Show Promise in Non-Small Cell Lung Cancer
- Moffitt Researchers Show Beta-Cutaneous HPV May Be Predictor of Squamous Cell Carcinoma
- Moffitt Researchers Identify New Relevant Target for PARP Inhibitor Talazoparib
- Novel Therapy Shows Promise for Lung Cancer Patients with Rare EGFR Mutation
- More news